[Prophylaxis of pancreatogenic disturbances by infusion of monomer-electrolyte solutions combined with dalargin].
Koval'skaia
K S
KS
Emel'ianov
S I
SI
D000818:Animals; D001810:Blood Volume / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D004285:Dogs; D004573:Electrolytes / Q000008:administration & dosage / Q000494:pharmacology*; D016308:Enkephalin, Leucine-2-Alanine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000494:pharmacology*; D007263:Infusions, Parenteral; D007408:Intestinal Absorption / Q000187:drug effects; D007421:Intestine, Small / Q000187:drug effects / Q000378:metabolism; D008099:Liver / Q000098:blood supply / Q000187:drug effects; D010195:Pancreatitis / Q000097:blood / Q000503:physiopathology / Q000517:prevention & control*; D012039:Regional Blood Flow / Q000187:drug effects
D004573:Electrolytes; D005765:Gastrointestinal Agents; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Profilaktika pankreatogennykh narysheniĭ posredstvom infuzii monomerno-élektrolitnykh rastvorov v komplekse s dalarginom.